Month: November 2023

Nov 04 2023

Uncategorized

Maine massacre: A THIRD of mass shooters have schizophrenia and 3MILLION Americans are living with reality-warping condition

by Clinical Editor

No Comments

Robert Card, an Army reservist and firearms instructor, was hospitalized in a mental health facility in June for an unspecified condition that experts, as well as his cousin, said showed...

Nov 04 2023

Uncategorized

Analyst Assessment On Reviva Pharmaceuticals’ Positive Schizophrenia Trial Data – Sees More Than 200% Upside In Stock

by Clinical Editor

No Comments

Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) shares are surging after the company released topline results of its pivotal Phase 3 RECOVER trial evaluating brilaroxazine, a serotonin-dopamine sig …

Nov 04 2023

Uncategorized

New clues to early development of schizophrenia

by Clinical Editor

No Comments

Schizophrenia is a severe neuropsychiatric disease that remains poorly understood and treated. Schizophrenia onset is typically in adolescence or early adulthood, but its underlying causes are thought …

Nov 04 2023

Uncategorized

Schizophrenia News

by Clinical Editor

No Comments

New Clues to Early Development of Schizophrenia Oct. 24, 2023 — Schizophrenia is a severe neuropsychiatric disease that remains poorly understood and treated. Schizophrenia onset is typically in …

Nov 03 2023

Uncategorized

Mental health: Killer’s mum calls for probe into son’s care errors – BBC.com

by Clinical Editor

No Comments

Mental health: Killer’s mum calls for probe into son’s care errors  BBC.com

Nov 03 2023

Uncategorized

Missing bipolar, schizophrenic man located – WJBF-TV

by Clinical Editor

No Comments

Missing bipolar, schizophrenic man located  WJBF-TV

Nov 03 2023

Uncategorized

Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a … – The Lancet

by Clinical Editor

No Comments

Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a …  The Lancet

Nov 03 2023

Uncategorized

Maine massacre: A THIRD of mass shooters have schizophrenia and 3MILLION Americans are living with reality-warping condition

by Clinical Editor

No Comments

Robert Card, an Army reservist and firearms instructor, was hospitalized in a mental health facility in June for an unspecified condition that experts, as well as his cousin, said showed...

Nov 03 2023

Uncategorized

Analyst Assessment On Reviva Pharmaceuticals’ Positive Schizophrenia Trial Data – Sees More Than 200% Upside In Stock

by Clinical Editor

No Comments

Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) shares are surging after the company released topline results of its pivotal Phase 3 RECOVER trial evaluating brilaroxazine, a serotonin-dopamine sig …

Nov 03 2023

Uncategorized

Karuna Therapeutics to Present Data from the EMERGENT Program Evaluating KarXT in Schizophrenia at the 2023 Neuroscience Education Institute Congress

by Clinical Editor

No Comments

Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people liv …